You have 9 free searches left this month | for more free features.

City

Basking Ridge (1)

Commack (1)

Houston (1)

New York (1)

Rockville Centre (1)

Sleepy Hollow (1)

Condition

Breast Cancer (1)

Metastatic Colorectal Cancer (1)

Metastatic Neuroendocrine Tumors (1)

Neuroendocrine Tumors (1)

Overall Status

Completed (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute (1)

M.D. Anderson Cancer Center (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Merck Sharp & Dohme LLC (3)

Bristol-Myers Squibb (1)

Commonwealth Foundation for Cancer Research (1)

Intervention

mk-0646 (3)

dasatinib (1)

fulvestrant (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

mk-0646

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Neuroendocrine Tumors, Metastatic Neuroendocrine Tumors Trial in United States (MK-0646)

Completed

Has Results

Neuroendocrine Tumors
Metastatic Neuroendocrine Tumors

MK-0646

Basking Ridge, New Jersey
+4 more

Oct 19, 2015

Breast Cancer Trial in Houston (Fulvestrant, MK-0646, Dasatinib)

Terminated

Has Results

Breast Cancer

Fulvestrant
+2 more

Houston, Texas

UT MD Anderson Cancer Center

Jan 21, 2015

Metastatic Colorectal Cancer Trial (MK-0646, Placebo)

Withdrawn

Metastatic Colorectal Cancer

MK-0646
Placebo

(no location specified)

Dec 2, 2011